NCT03912311

Brief Summary

The study will be to demonstrate that, in patients undergoing elective thoracic surgery, lung ultrasound (LUS) in OR is more sensitive, specific and accurate method than thoracic auscultation, for the evaluation of OLV. The aim of the study is to demonstrate how lung ultrasound can be considered an attractive alternative to the routine use of fiberbronchoscope as a first line diagnostic tool to verify the correct position of left double lumen tube.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 2, 2019

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

April 5, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 11, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 2, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 2, 2020

Completed
Last Updated

April 11, 2019

Status Verified

April 1, 2019

Enrollment Period

1 year

First QC Date

April 5, 2019

Last Update Submit

April 9, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • To compare trans- thoracic ultrasound method and auscultation in left selective intubation with LDLT, considering them as an alternative to fiberoptic bronchoscope use.

    Sensitivity, specificity and accuracy of ultrasound method and auscultation method as technique to verify LDLT correct placement, checked with fiberoptic bronchoscope.

    Through study completion, an average of 1 years

Secondary Outcomes (12)

  • Incidence of LDLT malpositioning

    Through study completion, an average of 1 years

  • Incidence of LDLT displacements after lateral positioning and during surgery

    Through study completion, an average of 1 years

  • Incidence of intra- and post-operating complications

    Through study completion, an average of 1 years

  • Presence/absence of lung sliding throw ultrasound scan in case of correct/incorrect position of LDLT

    Through study completion, an average of 1 years

  • Presence/absence of lung pulse throw ultrasound scan in case of correct/incorrect position of LDLT

    Through study completion, an average of 1 years

  • +7 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who underwent elective thoracic surgery (video-assisted thoracic surgery or open thoracotomy) requiring lung isolation and endotracheally intubation by left double lumen tube

You may qualify if:

  • Signed informed consent
  • Age \> 18 years
  • Patients who underwent elective thoracic surgery (video-assisted thoracic surgery or open thoracotomy) requiring lung isolation and endotracheally intubation by LDLT

You may not qualify if:

  • Not signed informed consent
  • Age \< 18 years
  • Previous history of thoracic surgery
  • Planned use of right double lumen tube
  • Pleural diseases: pleural spill, pneumothorax, mesothelioma, previous pleurodesis
  • Neuromuscular disease with proved diaphragmatic disfunction
  • Thoracic subcutaneous emphysema
  • Difficult endotracheally intubation or more than 3 attempts made by an experienced anesthesiologist or alternative device use
  • Pregnancy
  • Emergency surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Ospedaliera-Universitaria di Parma

Parma, 43125, Italy

Location

Study Officials

  • Michela Tosi, MD

    Azienda Ospedaliero-Universitaria di Parma

    PRINCIPAL INVESTIGATOR
  • Massimo Maffezzoni, MD

    Università di Parma

    PRINCIPAL INVESTIGATOR
  • Piercarlo Cottone, MD

    Università di Parma

    PRINCIPAL INVESTIGATOR
  • Stefania Lepori, MD

    Università di Parma

    PRINCIPAL INVESTIGATOR
  • Valentina Bellini, MD

    Università di Parma

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elena G. Bignami, MD professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesiology

Study Record Dates

First Submitted

April 5, 2019

First Posted

April 11, 2019

Study Start

April 2, 2019

Primary Completion

April 2, 2020

Study Completion

June 2, 2020

Last Updated

April 11, 2019

Record last verified: 2019-04

Locations